- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05641077
Virtual Visits for Postoperative Care Following Urogynecologic Surgery (VIDEO)
Are Virtual Visits for Delivery of Postoperative Care Following Urogynecologic Surgery Equal to Office Visits? The VIDEO Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is a randomized controlled noninferiority trial evaluating patient satisfaction with in-office versus virtual-video postoperative visits at six weeks following urogynecologic surgery. We aim to assess whether the intervention of virtual postoperative visit via videoconference technology is noninferior to the standard/traditional in-office postoperative visit for our primary outcome of patient satisfaction. The recruitment period will be 15 months (January 1, 2023 to March 31, 2024). The follow-up period for each participant will be 12 weeks after surgery.
The investigators will recruit patients of the Center for Urogynecology and Pelvic Reconstructive Surgery in the Department of Obstetrics/Gynecology and Women's Health Institute at the Cleveland Clinic scheduled to undergo major or minor surgery for pelvic organ prolapse and/or urinary incontinence. Participants will be prospectively identified by the primary surgeon during the patient's initial consultation when the decision is made to proceed with surgery for pelvic organ prolapse and/or urinary incontinence. Enrolled participants will be randomized to either the office visit arm or the virtual visit arm. Stratified block randomization will be used to ensure that the number of participants is equally distributed among the study groups and stratified by surgery level (major, minor).
Study instruments will be administered at the preoperative visit and the 6-week postoperative visit. The questionnaires for this study include the Patient Preparedness Questionnaire (PPQ), the Patient Satisfaction Questionnaire-18 (PSQ-18), and modified patient and provider preference questionnaires entitled, Patient Postoperative Visit Questionnaire and Provider Postoperative Visit Preference Questionnaire.
In addition to questionnaire responses, the investigators will collect the following information from the electronic medical record: Demographic data (e.g. age, race, parity, body mass index), perioperative data (e.g. surgery level major/minor, surgery type, concomitant procedures, estimated blood loss, operative time), six-week postoperative data (e.g. route of postoperative visit in-office/virtual, patient-initiated phone calls to surgeon's office, unanticipated outpatient visits, emergency department visits, hospital readmissions prior to the postoperative visit, adverse events prior to postoperative visit), and 6-12 week postoperative data (e.g. patient-initiated phone calls to surgeon's office, unanticipated outpatient visits, emergency department visits, hospital readmissions, and adverse events after the scheduled postoperative visit for up to 12 weeks after surgery).
A priori sample size calculation determined that 100 participants (50 per group) would allow for 80% power to assess a noninferiority margin of 5 points on the total PSQ-18, with a SD of 10 and significance level of 0.05. A minimum important difference has not been reported for the PSQ-18; however, previous studies using this tool demonstrated SD for total PSQ-18 score ranging between 2.6 and 11.8 and used a 5-point interval for the noninferiority margin. To account for an anticipated attrition rate of approximately 5%, we aimed to enroll a total of 106 participants (53 per group).
Patient satisfaction (PSQ-18) total scores, as well scores in each of the 7 PSQ-18 domains, will be treated as continuous data and checked for normality. Healthcare utilization will be analyzed individually (number of phone calls, number of outpatient visits, number of emergency department or urgent care visits, number of hospital readmissions), as well as a composite of all encounter types. Adverse events will be analyzed independently but also as a composite utilizing the Clavien-Dindo Grading System for surgical complications. Attitudes toward office/virtual visits will be analyzed by comparing proportions of patients and providers who prefer a virtual visit, prefer an office visit, or have no preference.
All analyses will be conducted using an intention-to-treat principle. Baseline demographic and clinical characteristics will be summarized using descriptive statistics. Normally-distributed continuous measures will be summarized using mean and standard deviation (SD), whereas those showing departure from normality will be summarized using median and interquartile range (IQR). Categorical measures will be summarized using number of participants and percentage. The primary end-point analysis will be designed to test whether patient satisfaction with a virtual postoperative visit is noninferior to an in-person postoperative visit, as determined by the total PSQ-18 at the scheduled postoperative visit. Noninferiority would be shown if the lower limit of the two-sided 95% confidence interval for the between-group mean difference in the primary endpoint (i.e., the difference between the mean PSQ-18 total score in the virtual group minus the mean PSQ-18 total score in the in-office group) is more than -5 points. Similar analyses will be performed for each secondary outcome. The noninferiority margin is defined as 5 points for the PSQ-18 total score and 0.5 points for the PSQ-18 domain scores, 10% absolute for composite healthcare resource utilization, and 25% absolute for composite adverse events. Planned exploratory subgroup analyses of patient satisfaction, healthcare resource utilization and adverse events based on surgery level will be additionally performed. All statistical analyses will be performed using JMP Pro version 17.0 software (SAS Institute, Cary, NC). Data will be managed in REDCap. Statistical support will be provided by the Cleveland Clinic Quantitative Health Sciences.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lannah Lorraine L Lua-Mailland, M.D., M.P.H.
- Phone Number: 216-444-0642
- Email: lual@ccf.org
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
Contact:
- Lannah Lorraine L Lua-Mailland, M.D., M.P.H.
- Phone Number: 216-444-0642
- Email: lual@ccf.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age greater than 18 years old
- Has technological capability to participate in videoconferencing (high-speed internet access with desktop computer or mobile device)
- Has decision-making capacity and able to provide informed consent for research participation
- Able to speak and read English
Exclusion Criteria:
- Patient requested to physically come in the office or have a virtual visit for her postoperative visit
- Planned concomitant surgery with another surgical team
- Office follow-up is deemed medically necessary by provider/surgeon
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Visit
Patients randomized to the experimental arm will be scheduled for and follow up with the surgeon or an advanced practice provider via a virtual visit using videoconference technology at 6 weeks after the anticipated date of surgery.
If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.
|
Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via a virtual visit using videoconference technology at 6 weeks after the anticipated date of surgery.
If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.
|
Active Comparator: Office Visit
Patients randomized to the active comparator arm will be scheduled for and follow up with the surgeon or an advanced practice provider via an in-office visit at 6 weeks after the planned date of surgery.
If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.
|
Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via an in-office visit at 6 weeks after the planned date of surgery.
If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: 6 weeks
|
Patient satisfaction will be measured by the Patient Satisfaction Questionnaire-18 (PSQ-18) at the 6-week postoperative visit.
The PSQ-18 is a validated 18-item questionnaire.
Responses to each question are scored on a five-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree).
The total score for the questionnaire ranges from 18 (dissatisfaction with medical care) to 90 (highest satisfaction with medical care).
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse events
Time Frame: 12 weeks
|
Urinary tract infection, neurologic injury, hemorrhage/hematoma, blood transfusion, wound infection and cellulitis, seroma, abscess, pyelonephritis, sepsis, vaginal fistula, vaginal dehiscence, deep venous thrombosis, pneumonia, drainage of abscess, delayed gastrointestinal injury, delayed genitourinary injury, ileus, small bowel obstruction, pulmonary embolism, myocardial infarction, cerebrovascular accident and stroke, death, mesh complication, readmission, reoperation, and composite outcome utilizing Clavien-Dindo Grading System for surgical complications
|
12 weeks
|
Rate of healthcare resource utilization
Time Frame: 12 weeks
|
Patient-initiated phone calls, unscheduled in-person/virtual office visits, emergency room or urgent care visits, and inpatient readmissions within 6 weeks following surgery and within 12 weeks following surgery
|
12 weeks
|
Patient preferences/attitudes toward virtual or office visits
Time Frame: 6 weeks
|
Patient and provider preferences/attitudes toward virtual or office visits will be evaluated based on responses to a questionnaire called "Patient Postoperative Visit Questionnaire."
This customized patient questionnaire has 7 items.
Responses to each item include "virtual visit is better," "no difference," "office visit is better," and "does not apply to me."
The questionnaire also includes an open-ended question, allowing the patient to select their preference for in-person or virtual visits for future postoperative visits and to specify their reason/s.
|
6 weeks
|
Provider preferences/attitudes toward virtual or office visits
Time Frame: 6 weeks
|
Provider preferences/attitudes toward virtual or office visits will be evaluated based on responses to a questionnaire called "Provider Postoperative Visit Preference Questionnaire."
This customized provider questionnaire has 10 questions.
Responses to each item include "virtual visit is better," "no difference," "office visit is better," and "does not apply to me."
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cecile A Ferrando, M.D., M.P.H., The Cleveland Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 22-1269
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Satisfaction, Patient
-
Shaukat Khanum Memorial Cancer Hospital & Research...Enrolling by invitationSatisfaction, Patient | SatisfactionPakistan
-
Cedars-Sinai Medical CenterTerminated
-
Universitair Ziekenhuis BrusselUnknownPatient Satisfaction | Patient PreferenceBelgium
-
HaEmek Medical Center, IsraelUnknownPatient Satisfaction | Patient Compliance
-
Acibadem UniversityCompletedPatient Satisfaction | Patient Relations, NurseTurkey
-
Samsun UniversityRecruiting
-
University of UtahActive, not recruitingPatient SatisfactionUnited States
-
Fatma mahannaCompleted
-
Medical University of ViennaCompletedPatient SatisfactionAustria
-
Ziekenhuis Oost-LimburgCompleted
Clinical Trials on Virtual Visit
-
University of RochesterDavis Phinney FoundationCompleted
-
Case Comprehensive Cancer CenterWithdrawn
-
The Cleveland ClinicRecruiting
-
CAMC Health SystemSarah & Pauline Maier Foundation, Inc.; WVCTSINot yet recruitingVascular Diseases
-
Wake Forest University Health SciencesAmerican College of SurgeonsCompletedCholecystectomy, Laparoscopic | Appendectomy, Laparoscopic | Cholecystectomy, RoboticUnited States
-
The Cleveland ClinicCompletedHeart Failure, Systolic | Heart Failure With Preserved Ejection FractionUnited States
-
The Cleveland ClinicCompleted
-
Sakarya UniversityNot yet recruitingSatisfaction | Attachment | Virtual
-
Brigham and Women's HospitalTerminatedHeart Failure | Stroke | Hypertension | Diabetes Mellitus | Hyperlipidemia | BPHUnited States